Lucas Haniel Araujo Ventura,Licia Torres,Giovanna Caliman Camatta,Jofer Zamame,Monique Macedo Coelho,Cecilia Horta Ramalho-Pinto,Joao Gervazio,Felipe Caixeta,Leandro Nascimento,Mariana Almeida Oliveira,Vinicius Dantas Martins,Marcos Felipe Oliveira,Murilo Soares Costa,Hugo Itaru Sato,Henrique Cerqueira Guimaraes,Rafael Barbuto,Ana Paula Veiga,Najara Ataide,Gabriela Prandi Caetano,Sarah Rangon,Mauro Junior,Fernanda Calvo Fortes,Luciana Zuccherato,Elaine Speziali Farias,Veronica Coelho,Roberto Avritchir,Rafael Souza,Marina Cacador Ayupe,Caio Loureiro,Ana Clara Mota Neves,Maria Eduarda Passos,Pauline Leite,Santuza Teixeira,Unai Tupinambas,Liza Felicori Vilela,Gabriela Silveira-Nunes,Tatiani Uceli Maioli,Denise Morais Fonseca,Andrea Teixeira-Carvalho,Ana Maria Caetano Faria

Abstract:In this study we tested the hypothesis that the immunosenescence profile could account for the disproportional susceptibility of the elderly to severe forms of COVID-19. The immunological profiles of volunteers residing in endemic and non-endemic areas for chronic infectious diseases were analyzed at early stage of SARS-CoV-2 infection. A unique signature of inflammatory plasma mediators was identified in COVID-19 volunteers when compared to individuals with other flu-like syndromes. COVID-19 severity correlated with high levels of inflammatory mediators; among them, CXCL9, a serum marker of aging. Patients who progressed to hospitalization displayed high frequencies of CD8+ and CD4+ T cells expressing exhaustion and senescence markers and showed reduced and more mature B cell repertoires, which are typical of senescence. They also had an acceleration of epigenetic age measured by DNA methylation. Therefore, severe COVID-19 correlated with phenotypic, functional, and epigenetic features of accelerated immunosenescence at onset of infection.

Immunosenescence profile is associated with increased susceptibility to severe COVID-19